{"ok":true,"nota":{"id":"33b237d0d1361350","slug":"un-indice-de-sangre-simple-parece-anticipar-cuanto-viven-las-personas--33b237","titulo":"Un índice de sangre simple parece anticipar cuánto viven las personas con cáncer de pulmón","resumen":"Revisaron once estudios con 13 cohortes para evaluar si el índice CALLY, que combina inflamación, albúmina y linfocitos en sangre, predice la supervivencia en cánceres de pulmón primarios. Hicieron un metaanálisis con evaluación de la calidad de la evidencia.","fuente":"medrxiv","fuenteNombre":"medRxiv · preprints","color":"#1f7a4d","autor":"Shamohammadi, M., Yarahmadi, D., Naseri Rad, F., Patel, I., Yarahmadi, M., Rashidi, A., Yarahmadi, A., Kordestani Moghad","url":"https://www.medrxiv.org/content/10.64898/2026.10.18.26365819v1?rss=1","imagen":"/hoy/portada/33b237d0d1361350","tema":"salud","subtemas":["cancer de pulmon","analisis de sangre","pronostico","metaanalisis","inflamacion"],"entidades":[],"formato":"dato","entretenimiento":false,"pubTs":"2026-10-20T00:00:00.000Z","indexTs":"2026-10-20T23:32:18.927Z","hash":"4a04a27be4cd3485485412dcdd528be81b2f5729d1a77f95800cad27aa2c599a","tsa":{"time":"Oct 20 23:33:04 2026 GMT","provider":"freetsa.org","sobre":"sello"},"stats":{"views":0,"likes":0,"clicks":0,"dwell":0},"tipo":"normal","registro":"hallazgo","porQueImporta":"Al juntar los estudios, el índice aparece asociado con la supervivencia de los pacientes, y la evaluación GRADE indica cuánta confianza merece cada resultado. Para alguien con un familiar en tratamiento, un análisis de sangre barato podría ayudar a los equipos médicos a ajustar expectativas y estrategias. Pero el índice todavía no se usa para decidir tratamientos, y falta validarlo en más poblaciones. Es una herramienta prometedora que aún tiene que demostrar que mejora las decisiones reales.","quienFirma":"medRxiv (preprint; institución principal no identificada en el resumen)","confianza":"preprint","consulta":null},"sello":{"hash":"4a04a27be4cd3485485412dcdd528be81b2f5729d1a77f95800cad27aa2c599a","sello":"98abbbfe959272e0c9c9af751ff77c0b2d945fd6523e00e90e890230e3ee25f0","beacon":{"drand":{"cadena":"8990e7a9aaed2ffed73dbd7092123d6f289930540d7651336225dc172e51b2ce","ronda":6570272,"aleatorio":"bda24f270320f1e2527293c15ec727a66bdf246506dc957c7c9b6bd88c84b428","tiempo":"2026-10-20T23:33:00.000Z"},"nist":{"cadena":2,"pulso":1992341,"salida":"FA817D353D94A91CF41B4C174AAAB25209FED37DED6709559D325A28B103253A89D243C5C71B384CB4111753AA993F97FAC5CFB1C3257FDFA18ADA31FEE94D9A","tiempo":"2026-10-20T23:32:00.000Z"},"noAntes":"2026-10-20T23:33:00.000Z"},"verificacion":{"drand":true,"nist":true},"tsa":{"time":"Oct 20 23:33:04 2026 GMT","provider":"freetsa.org","sobre":"sello"},"original":{"titulo":"Prognostic significance of the C-reactive protein-albumin-lymphocyte (CALLY) index in primary lung malignancies: a systematic review and meta-analysis with GRADE assessment","descripcion":"Background: The C-reactive protein-albumin-lymphocyte (CALLY) index integrates systemic inflammation, nutritional status, and immune function. We evaluated its association with survival in primary lung malignancies. Methods: Embase, PubMed, Scopus, and Web of Science were searched from inception to 18 September 2026. Risk of bias was assessed using the Quality In Prognosis Studies tool. Hazard ratios (HRs) were synthesized using random-effects models with restricted maximum likelihood estimation and Hartung-Knapp adjustment. Sensitivity analyses, subgroup analyses, and meta-regression examined robustness and heterogeneity. Results: Eleven studies contributed 13 cohorts to the overall surviva","pubDate":"2026-10-20","url":"https://www.medrxiv.org/content/10.64898/2026.10.18.26365819v1?rss=1"},"indexado":"2026-10-20T23:32:18.927Z"}}